Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Glomerulonephritis, IGA, Date of authorisation: 15/07/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Glomerulonephritis, IGA, Date of authorisation: 15/07/2022, Revision: 5, Status: Authorised